Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


11.03.2019

1 Am Heart J
1 Am J Epidemiol
1 Angiology
1 BMC Ophthalmol
1 BMC Pediatr
1 BMJ
1 Br J Ophthalmol
3 Diabet Med
3 Diabetes
8 Diabetes Care
9 Diabetes Obes Metab
3 Diabetologia
2 Eur J Endocrinol
1 J Am Soc Nephrol
7 J Clin Endocrinol Metab
2 J Diabetes Complications
2 JAMA
2 Lancet Diabetes Endocrinol
1 N Engl J Med
1 Pediatr Diabetes
6 PLoS One
1 Retina


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. SHARMA A, Mentz RJ, Granger BB, Heitner JF, et al
    Utilizing mobile technologies to improve physical activity and medication adherence in patients with heart failure and diabetes mellitus: Rationale and design of the TARGET-HF-DM Trial.
    Am Heart J. 2019;211:22-33.
    PubMed     Text format     Abstract available


    Am J Epidemiol

  2. LIM S, Miller-Archie SA, Singh TP, Wu WY, et al
    Supportive housing and its impact on diabetes among New York City homeless population.
    Am J Epidemiol. 2019 Mar 5. pii: 5369506. doi: 10.1093.
    PubMed     Text format     Abstract available


    Angiology

  3. PAPAZAFIROPOULOU AK, Patsourakos NG, Melidonis A
    Prediabetes and Atherosclerotic Disease.
    Angiology. 2019;70:101-102.
    PubMed     Text format    


    BMC Ophthalmol

  4. ZHAO MH, Hu J, Li S, Wu Q, et al
    Correction to: P66Shc expression in diabetic rat retina.
    BMC Ophthalmol. 2019;19:64.
    PubMed     Text format     Abstract available


    BMC Pediatr

  5. RASOUL MA, Haider MZ, Al-Mahdi M, Al-Kandari H, et al
    Relationship of four vitamin D receptor gene polymorphisms with type 1 diabetes mellitus susceptibility in Kuwaiti children.
    BMC Pediatr. 2019;19:71.
    PubMed     Text format     Abstract available


    BMJ

  6. NEWMAN M
    Questions over future of global diabetes group as founding members resign.
    BMJ. 2019;364:l995.
    PubMed     Text format    


    Br J Ophthalmol

  7. SCHREUR V, Ng H, Nijpels G, Stefansson E, et al
    Validation of a model for the prediction of retinopathy in persons with type 1 diabetes.
    Br J Ophthalmol. 2019 Mar 1. pii: bjophthalmol-2018-313539.
    PubMed     Text format     Abstract available


    Diabet Med

  8. HOLT RIG
    Predicting the future: Diabetes and Brexit.
    Diabet Med. 2019;36:397-398.
    PubMed     Text format    

  9. THAYAKARAN R, Perrins M, Gokhale KM, Kumaran S, et al
    Impact of glycaemic control on fracture risk in 5368 people with newly diagnosed Type 1 diabetes: a time-dependent analysis.
    Diabet Med. 2019 Mar 8. doi: 10.1111/dme.13945.
    PubMed     Text format     Abstract available


  10. Abstracts of the Diabetes UK Professional Conference 2019, ACC Liverpool, Liverpool, 6-8 March 2019.
    Diabet Med. 2019;36 Suppl 1:5-174.
    PubMed     Text format    


    Diabetes

  11. JUNGTRAKOON P, Shirakawa J, Buranasupkajorn P, Gupta MK, et al
    Loss-of-Function Mutation in Thiamine Transporter 1 in a Family with Autosomal Dominant Diabetes.
    Diabetes. 2019 Mar 4. pii: db17-0821. doi: 10.2337/db17-0821.
    PubMed     Text format     Abstract available

  12. AATSINKI SM, Elkhwanky MS, Kummu O, Karpale M, et al
    Fasting-Induced Transcription Factors Repress Vitamin D Bioactivation, a Mechanism for Vitamin D Deficiency in Diabetes.
    Diabetes. 2019 Mar 4. pii: db18-1050. doi: 10.2337/db18-1050.
    PubMed     Text format     Abstract available

  13. RUSSELL MA, Redick SD, Blodgett DM, Richardson SJ, et al
    HLA Class II Antigen Processing and Presentation Pathway Components Demonstrated by Transcriptome and Protein Analyses of islet beta-Cells from Donors with Type 1 Diabetes.
    Diabetes. 2019 Mar 4. pii: db18-0686. doi: 10.2337/db18-0686.
    PubMed     Text format     Abstract available


    Diabetes Care

  14. CUMMINGS DM, Lutes LD, Littlewood K, Solar C, et al
    Randomized Trial of a Tailored Cognitive Behavioral Intervention in Type 2 Diabetes With Comorbid Depressive and/or Regimen-Related Distress Symptoms: 12-Month Outcomes From COMRADE.
    Diabetes Care. 2019 Mar 4. pii: dc18-1841. doi: 10.2337/dc18-1841.
    PubMed     Text format     Abstract available

  15. HAINSWORTH DP, Bebu I, Aiello LP, Sivitz W, et al
    Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study.
    Diabetes Care. 2019 Mar 4. pii: dc18-2308. doi: 10.2337/dc18-2308.
    PubMed     Text format     Abstract available

  16. PERKINS BA, Bebu I, de Boer IH, Molitch M, et al
    Risk Factors for Kidney Disease in Type 1 Diabetes.
    Diabetes Care. 2019 Mar 4. pii: dc18-2062. doi: 10.2337/dc18-2062.
    PubMed     Text format     Abstract available

  17. DANNE T, Cariou B, Buse JB, Garg SK, et al
    Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program.
    Diabetes Care. 2019 Mar 4. pii: dc18-2149. doi: 10.2337/dc18-2149.
    PubMed     Text format     Abstract available

  18. YAMANOUCHI M, Furuichi K, Hoshino J, Toyama T, et al
    Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.
    Diabetes Care. 2019 Mar 4. pii: dc18-1320. doi: 10.2337/dc18-1320.
    PubMed     Text format     Abstract available

  19. HAZUDA HP, Gaussoin SA, Wing RR, Yanovski SZ, et al
    Long-term Association of Depression Symptoms and Antidepressant Medication Use With Incident Cardiovascular Events in the Look AHEAD (Action for Health in Diabetes) Clinical Trial of Weight Loss in Type 2 Diabetes.
    Diabetes Care. 2019 Mar 4. pii: dc18-0575. doi: 10.2337/dc18-0575.
    PubMed     Text format     Abstract available

  20. WEINSTOCK RS, Braffett BH, McGuigan P, Larkin ME, et al
    Self-Monitoring of Blood Glucose in Youth-Onset Type 2 Diabetes: Results From the TODAY Study.
    Diabetes Care. 2019 Mar 4. pii: dc18-1854. doi: 10.2337/dc18-1854.
    PubMed     Text format     Abstract available

  21. MCINTOSH EC, Nation DA
    Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer Disease.
    Diabetes Care. 2019 Mar 4. pii: dc18-1399. doi: 10.2337/dc18-1399.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  22. KIM K, Unni S, Brixner DI, Thomas SM, et al
    Longitudinal Changes in HbA1c following Treatment Intensification after Inadequate Response to Two Oral Antidiabetic Agents in Patients with Type 2 Diabetes.
    Diabetes Obes Metab. 2019 Mar 7. doi: 10.1111/dom.13694.
    PubMed     Text format     Abstract available

  23. BAILEY TS, Zhou FL, Gupta RA, Preblick R, et al
    Glycemic goal attainment and hypoglycemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real-world results from the DELIVER Naive cohort study.
    Diabetes Obes Metab. 2019 Mar 6. doi: 10.1111/dom.13693.
    PubMed     Text format     Abstract available

  24. DUNKLEY AJ, Fitzpatrick C, Gray LJ, Waheed G, et al
    Incidence and severity of hypoglycaemia in type 2 diabetes by treatment regimen: a UK multi-site 12-month prospective observational study.
    Diabetes Obes Metab. 2019 Mar 6. doi: 10.1111/dom.13690.
    PubMed     Text format     Abstract available

  25. LAN NS, Fegan PG, Yeap BB, Rankin JM, et al
    Icosapent ethyl for dyslipidaemia in patients with diabetes and coronary artery disease: act now to reduce it.
    Diabetes Obes Metab. 2019 Mar 4. doi: 10.1111/dom.13689.
    PubMed     Text format     Abstract available

  26. ARAKI E, Yamashita S, Arai H, Yokote K, et al
    The Efficacy and Safety of Pemafibrate in Patients with Type 2 Diabetes and Elevated Triglyceride levels: 52-Week Data From The PROVIDE Study.
    Diabetes Obes Metab. 2019 Mar 4. doi: 10.1111/dom.13686.
    PubMed     Text format     Abstract available

  27. MEIFFREN G, Herbrand T, Anastassiadis E, Klein O, et al
    Better glycemic control with BioChaperone Combo (BC Combo) than with insulin lispro Mix25 (LMix) or separate glargine & lispro (G+L) administrations after a test meal in subjects with type 2 diabetes (T2DM).
    Diabetes Obes Metab. 2019 Mar 3. doi: 10.1111/dom.13685.
    PubMed     Text format     Abstract available

  28. UNGER J, Allison DC, Carlton M, Lakkole K, et al
    Trial design and baseline data for LIRA-PRIME: a randomized trial investigating the efficacy of liraglutide in controlling glycemia in type 2 diabetes in a primary care setting.
    Diabetes Obes Metab. 2019 Mar 3. doi: 10.1111/dom.13682.
    PubMed     Text format     Abstract available

  29. DENNIS JM, Henley WE, McGovern AP, Farmer AJ, et al
    Time trends in prescribing of type 2 diabetes drugs, glycemic response and risk factors: a retrospective analysis of primary care data, 2010-2017.
    Diabetes Obes Metab. 2019 Mar 3. doi: 10.1111/dom.13687.
    PubMed     Text format     Abstract available

  30. JI L, Liu Y, Miao H, Xie Y, et al
    Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia.
    Diabetes Obes Metab. 2019 Mar 4. doi: 10.1111/dom.13681.
    PubMed     Text format     Abstract available


    Diabetologia

  31. KRAMER CK, Campbell S, Retnakaran R
    Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis.
    Diabetologia. 2019 Mar 7. pii: 10.1007/s00125-019-4840.
    PubMed     Text format     Abstract available

  32. CHENG Y, Yu X, Zhang J, Chang Y, et al
    Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-A(y)/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes.
    Diabetologia. 2019 Mar 5. pii: 10.1007/s00125-019-4838.
    PubMed     Text format     Abstract available

  33. CHAN JY, Lee K, Maxwell EL, Liang C, et al
    Macrophage alterations in islets of obese mice linked to beta cell disruption in diabetes.
    Diabetologia. 2019 Mar 4. pii: 10.1007/s00125-019-4844.
    PubMed     Text format     Abstract available


    Eur J Endocrinol

  34. VALDES S, Doulatram Gamgaram VK, Lago A, Garcia-Torres F, et al
    Ambient temperature and prevalence of diabetes and insulin resistance in the Spanish population. Di@bet.es study.
    Eur J Endocrinol. 2019 Mar 1. pii: EJE-18-0818.R2. doi: 10.1530/EJE-18-0818.
    PubMed     Text format     Abstract available

  35. FAGHERAZZI G, Gusto G, El Fatouhi D, Mancini FR, et al
    Mentally tiring work and type 2 diabetes in women: a 22-year follow-up study.
    Eur J Endocrinol. 2019;180:257-263.
    PubMed     Text format     Abstract available


    J Am Soc Nephrol

  36. FU J, Akat KM, Sun Z, Zhang W, et al
    Single-Cell RNA Profiling of Glomerular Cells Shows Dynamic Changes in Experimental Diabetic Kidney Disease.
    J Am Soc Nephrol. 2019 Mar 7. pii: ASN.2018090896. doi: 10.1681/ASN.2018090896.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  37. INAISHI J, Hirakawa Y, Horikoshi M, Akiyama M, et al
    Association between genetic risk and development of type 2 diabetes in a general Japanese population: The Hisayama Study.
    J Clin Endocrinol Metab. 2019 Mar 4. pii: 5366824. doi: 10.1210/jc.2018-01782.
    PubMed     Text format     Abstract available

  38. BARB D, Bril F, Kalavalapalli S, Cusi K, et al
    Plasma Fibroblast Growth Factor 21 is Associated with Severity of Nonalcoholic Steatohepatitis in Patients with Obesity and Type 2 Diabetes.
    J Clin Endocrinol Metab. 2019 Mar 8. pii: 5371245. doi: 10.1210/jc.2018-02414.
    PubMed     Text format     Abstract available

  39. CHEN SC, Shepherd S, McMillan M, McNeilly J, et al
    Skeletal Fragility & Its Clinical Determinants In Children With Type 1 Diabetes.
    J Clin Endocrinol Metab. 2019 Mar 8. pii: 5371250. doi: 10.1210/jc.2019-00084.
    PubMed     Text format     Abstract available

  40. BERGMANN NC, Lund A, Gasbjerg LS, Jorgensen NR, et al
    Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men without Diabetes.
    J Clin Endocrinol Metab. 2019 Mar 8. pii: 5371246. doi: 10.1210/jc.2019-00008.
    PubMed     Text format     Abstract available

  41. STECK AK, Dong F, Taki I, Hoffman M, et al
    Continuous Glucose Monitoring Predicts Progression to Diabetes in Autoantibody Positive Children.
    J Clin Endocrinol Metab. 2019 Mar 7. pii: 5370167. doi: 10.1210/jc.2018-02196.
    PubMed     Text format     Abstract available

  42. KASEVA N, Vaarasmaki M, Sundvall J, Matinolli HM, et al
    Gestational diabetes, but not pre-pregnancy overweight predicts cardio-metabolic markers in offspring twenty years later.
    J Clin Endocrinol Metab. 2019 Mar 5. pii: 5368422. doi: 10.1210/jc.2018-02743.
    PubMed     Text format     Abstract available

  43. HAMBLIN PS, Wong R, Ekinci EI, Fourlanos S, et al
    SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission.
    J Clin Endocrinol Metab. 2019 Mar 5. pii: 5368425. doi: 10.1210/jc.2019-00139.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  44. HOLTE KB, Svanteson M, Hanssen KF, Haig Y, et al
    Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study.
    J Diabetes Complications. 2019 Jan 31. pii: S1056-8727(18)31206.
    PubMed     Text format     Abstract available

  45. MORIYA T, Yamagishi T, Matsubara M, Ouchi M, et al
    Serial renal biopsies in normo- and microalbuminuric patients with type 2 diabetes demonstrate that loss of renal function is associated with a reduction in glomerular filtration surface secondary to mesangial expansion.
    J Diabetes Complications. 2019 Feb 10. pii: S1056-8727(18)31002.
    PubMed     Text format     Abstract available


    JAMA

  46. BALDUCCI S, D'Errico V, Haxhi J, Sacchetti M, et al
    Effect of a Behavioral Intervention Strategy on Sustained Change in Physical Activity and Sedentary Behavior in Patients With Type 2 Diabetes: The IDES_2 Randomized Clinical Trial.
    JAMA. 2019;321:880-890.
    PubMed     Text format     Abstract available

  47. NAGPAL SJS, Chari ST
    Immunoglobulin G4 Levels.
    JAMA. 2019;321:202-203.
    PubMed     Text format    


    Lancet Diabetes Endocrinol

  48. ZINMAN B, Bhosekar V, Busch R, Holst I, et al
    Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial.
    Lancet Diabetes Endocrinol. 2019 Mar 1. pii: S2213-8587(19)30066.
    PubMed     Text format     Abstract available

  49. DEL PRATO S
    Rational combination therapy for type 2 diabetes.
    Lancet Diabetes Endocrinol. 2019 Mar 1. pii: S2213-8587(19)30069.
    PubMed     Text format    


    N Engl J Med

  50. RIDKER PM, Everett BM, Pradhan A, MacFadyen JG, et al
    Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
    N Engl J Med. 2019;380:752-762.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  51. ASH GI, Joiner KL, Savoye M, Baker JS, et al
    Feasibility and Safety of a Group Physical Activity Program for Youth with Type 1 Diabetes.
    Pediatr Diabetes. 2019 Mar 4. doi: 10.1111/pedi.12841.
    PubMed     Text format     Abstract available


    PLoS One

  52. ALECSANDRU D, Barrio A, Andia V, Cruz E, et al
    Pancreatic autoimmunity: An unknown etiology on patients with assisted reproductive techniques (ART)-recurrent reproductive failure.
    PLoS One. 2018;13:e0203446.
    PubMed     Text format     Abstract available

  53. IM SS, Park HY, Shon JC, Chung IS, et al
    Plasma sphingomyelins increase in pre-diabetic Korean men with abdominal obesity.
    PLoS One. 2019;14:e0213285.
    PubMed     Text format     Abstract available

  54. IRACE C, Cutruzzola A, Carbotti DF, Mastroianni S, et al
    Hypoglycemia does not affect the progression of preclinical atherosclerosis in subjects with type 2 diabetes.
    PLoS One. 2019;14:e0212871.
    PubMed     Text format     Abstract available

  55. MIN KL, Koo H, Choi JJ, Kim DJ, et al
    Utilization patterns of insulin for patients with type 2 diabetes from national health insurance claims data in South Korea.
    PLoS One. 2019;14:e0210159.
    PubMed     Text format     Abstract available

  56. KAJAL A, Singh R
    Coriandrum sativum seeds extract mitigate progression of diabetic nephropathy in experimental rats via AGEs inhibition.
    PLoS One. 2019;14:e0213147.
    PubMed     Text format     Abstract available

  57. SCHIERLOH U, Wilinska ME, Pit-Ten Cate IM, Baumann P, et al
    Lower plasma insulin levels during overnight closed-loop in school children with type 1 diabetes: Potential advantage? A randomized cross-over trial.
    PLoS One. 2019;14:e0212013.
    PubMed     Text format     Abstract available


    Retina

  58. AFARID M, Meshksar A, Salehi A, Safarpour MM, et al
    EVALUATION OF THE EFFECT OF TOPICAL INTERFERON alpha2b AS A COMPLEMENTARY TREATMENT OF MACULAR EDEMA OF PATIENTS WITH DIABETIC RETINOPATHY: A Double-Blind Placebo-Controlled Randomized Clinical Trial Study.
    Retina. 2019 Feb 6. doi: 10.1097/IAE.0000000000002465.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: